India Biosimilar Market Size | Growth & Forecast 2031

Q: Which therapeutic areas are leading in biosimilar adoption?

Oncology, rheumatology, endocrinology (diabetes), and nephrology are the primary segments utilizing biosimilars extensively.

Q: What are the key challenges in market adoption?

Physician skepticism, lack of awareness among patients, interchangeability concerns, and complex manufacturing are notable hurdles.

Q: What鈥檚 driving global biosimilar growth?

Patent expiries of biologics, cost-efficiency, supportive regulations, and rising biologic demand are major growth drivers.

Q: How are new technologies influencing the biosimilar space?

Advanced bioprocessing, bio analytics, and AI-driven comparative modeling are accelerating biosimilar development and regulatory approvals.

Q: How does 6W market outlook report help businesses in making decisions?

6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.

Q: Do you also provide customisation in the market study?

Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

India Biosimilar Market Size | Share, Trends & Forecast 2031

Code: MTA4115

Publication Date: Jun 2025

What is the India Biosimilar Market Size & Growth Rate?

According to 绿帽社 internal database and industry insights, India Biosimilar Market is expected to grow at a CAGR of 16.7% during the forecast period from 2025 to 2031.

The growth is being driven by patent expiries of major biologics, cost-effectiveness of biosimilars, and rising demand for biologic treatments for chronic diseases like cancer, diabetes, and autoimmune disorders.

Key Growth Drivers of the Market

Rising rate of chronic illnesses and aging.
Increasing cost of healthcare that is driving demand of cheaper substitutes.
Patent cliffs of blockbuster biologics (e.g. Humira, Enbrel, Herceptin).
Positive regulatory avenues in the EU, the US (FDA), and the developing economies.
The increasing investment in the biosimilar R&D and manufacture capacities.
The joint efforts of pharmaceutical and biotech companies.

India Biosimilar Market Trends

India Biosimilar Market is expected to be shaped by increasing approvals across oncology and autoimmune therapies, along with wider adoption in emerging markets. The growing use of real-world evidence to support interchangeability is further strengthening market acceptance. The company is also improving the quality of its products and regulatory adherence through innovation in tools of comparability of analysis as well as cell line development. Another important trend that is developing is personalized biosimilars that add to a more competitive and dynamic environment.